MedTrace Logo

Drug Interaction Study With NS2359 and Cocaine in Cocaine Experienced Volunteers - 1

NCT00032916 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2017-01-11

No results posted yet for this study

Summary

The purpose of this study is to conduct a drug interaction study with NS2359 and cocaine in cocaine experienced volunteers.

Conditions

  • Cocaine-Related Disorders
  • Drug Administration Schedule
  • Infusions, Intravenous

Interventions

DRUG

NS2359

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    lead NIH

Principal Investigators

  • Louis Cantilena, M.D. · Uniformed Services University of Health Science

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-06-30
Completion
2002-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00032916 on ClinicalTrials.gov